← Back to Search

Telehealth Intervention for COVID-19 (GET2HOME Trial)

N/A

Waitlist Available

Research Sponsored by Children's Hospital Medical Center, Cincinnati

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7-, 30-, 60-, and 90-days post-discharge

Awards & highlights

No Placebo-Only Group

Summary

This trial tests if a care bundle improves care & outcomes for hospitalized COVID-19 patients.

Who is the study for?

This trial is for children with complex chronic diseases, as determined by a specific score (PMCA score of 3), and their families. They must have been discharged from the pediatric hospital medicine service at the study's hospital. It excludes those living independently without a guardian, in skilled nursing facilities, admitted for end-of-life care or severe mental health crises, previously enrolled in the study, or under county custody.

What is being tested?

The GET2HOME Intervention bundle is being tested to see if it can improve care for children with chronic conditions through telehealth. The effectiveness of this intervention will be evaluated after discharge from pediatric services.

What are the potential side effects?

Since this trial involves a non-medical intervention focused on telehealth and team engagement rather than drugs or medical procedures, traditional side effects are not applicable. However, there may be indirect impacts on family dynamics or stress levels.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7-, 30-, 60-, and 90-days post-discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7-, 30-, 60-, and 90-days post-discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7-, 30-, 60-, and 90-days post-discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Global Quality of Life Scale

Return to baseline

Other study objectives

Caregiver time to manage illness post-discharge

Medical and non-medical out-of-pocket costs

Percent of participants with transition process failures

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: GET2HOME InterventionExperimental Treatment1 Intervention

The GET2HOME intervention includes: 1) a pre-discharge telehealth huddle with the family, inpatient team, primary care team, and home care nursing; 2) a visual discharge task tracker (DTT) to monitor progress across care management tasks; and if desired by family and primary care 3) a post-discharge telehealth huddle 2-7 days after discharge with the family, inpatient team, primary care team, and home care nursing

Group II: Standard Hospital-Based Care CoordinationActive Control1 Intervention

Patients and families randomized to this arm will receive best practice standard of care hospital-based transition planning in the hospital with routine outpatient care team follow-up post-discharge.

Do I qualify?Apply below to find out